Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

NCT00424255 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Head and Neck

Interventions

DRUG: Lapatinib
RADIATION: Chemoradiation
OTHER: Placebo

Sponsor

GlaxoSmithKline